SLCO1B1 and osteosarcoma: Notably, these findings in patients with ALL may not universally apply to other MTX-sensitive diseases, demonstrated by the lack of a significant association between SLCO1B1 SNPs and MTX clearance in patients with osteosarcoma [29].